IMS Health to Announce Full-Year and Fourth-Quarter 2015 Results On February 3, 2016

DANBURY, Conn.--()--IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS) will issue its full-year and fourth-quarter 2015 financial results before the market opens on Wednesday, February 3, 2016. The earnings release and accompanying financial information will be posted on the IMS Health Investor Relations website at

IMS Health’s management team will host a conference call and webcast to discuss the company’s results at 9:00 a.m. Eastern Time on February 3. Interested parties are invited to listen to the live event and view the presentation slides via webcast on IMS Health’s Investor Relations website at The discussion also will be available by dialing +1-800-926-7891 in the U.S. and Canada, or +1-212-231-2903 for international callers.

A replay of the webcast will be available approximately two hours after the conclusion of the live event on February 3. To access the webcast recording, visit

About IMS Health

IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,500 services experts connect configurable SaaS applications to 10+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at



IMS Health Holdings
Investor Relations
Tom Kinsley, +1.203.448.4691
Media Relations
Tor Constantino, +1.484.567.6732

IMS Health Holdings, Inc.